FINWIRES · TerminalLIVE
FINWIRES

アドバンテージ・エナジー、第1四半期に黒字転換。売上高は減少。

By

-- アドバンテージ・エナジー(AAV.TO)は木曜の取引終了後、天然ガスと液化天然ガスの売上高は前年同期比で減少したものの、第1四半期は黒字転換したと発表した。 天然ガスを主力とするカナダ西部を拠点とする同社は、第1四半期に2,950万ドル(1株当たり0.17ドル)の利益を計上した。前年同期は2,900万ドル(1株当たり0.17ドル)の損失だった。ファクトセットは1株当たり0.27ドルの利益を予想していた。 天然ガスと液化天然ガスの売上高は、前年同期の2億2,180万ドルから2億690万ドルに減少した。ファクトセットは2億1,060万ドルの売上高を予想していた。 「アドバンテージ社は、非常に効率的な成長とフリーキャッシュフローの拡大期に入っており、2026年下半期の設備投資計画は1億ドル未満です。生産量は2026年第3四半期から2027年にかけて平均約9万バレル相当/日になると見込まれています」と同社は述べ、天然ガス価格が低迷した場合でも、ヘッジと市場の多角化によって、2026年下半期には純負債を4億ドルから5億ドルに削減できると付け加えた。 声明によると、この業績はアドバンテージ・エナジー社のみのものであり、子会社のエントロピー社は含まれていない。 アドバンテージ社の株価はトロント証券取引所で0.01ドル下落し、10.33ドルで取引を終えた。

Related Articles

Research

Research Alert: CFRA Reiterates Sell Opinion On Shares Of Hilton Worldwide Holdings Inc

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target by $9 to $293, or 32x our 2026 EPS estimate (unchanged) and in line with shares' five-year average forward multiple. We raise our 2026 EPS estimate to $9.16 from $8.88 and lower 2027's to $10.03 from $10.20. Following Q1 results that beat expectations and included raised guidance, we maintain our 2-STARS (Sell) rating. U.S. RevPAR performance broadened from primarily luxury and upper upscale segments to include more meaningful midscale contribution, which management attributes to the return of middle- and low-income consumers. However, we note Q1 results also included ADR deceleration, particularly among luxury hotels, which historically drive significant profit contribution. HLT's Q2 EBITDA guidance of $1,015-$1,035 million being below the $1,081 million consensus suggests luxury pricing power is weakening faster than midscale volume can offset. While the broadening demand trend is positive, we believe slowing luxury tailwinds limit upside at current valuation levels.

$HLT
Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Universal Health Services

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target to $200 from $243, reflecting an 8.7x multiple of our 2026 EPS estimate, below peer multiples and a discount to UHS's five-year historical forward average of 11.9x. We lower our 2026 EPS forecast to $22.95 from $23.39 and cut our 2027 view to $25.48 from $25.67. Q1 inpatient volumes were flat on a same-facility basis, with seasonal headwinds from unfavorable winter weather and a milder flu/respiratory illness period. The recent expiration of ACA EPTCs also posed challenges, as UHS estimates a near 5% drop in ACA adjusted admissions relative to Q1 2025. UHS maintained its prior forecast of a 25%-30% decline in ACA exchange volumes during the full year, which represented around 6% of the acute care business adjusted admissions in 2025 and under 5% of the acute care segment revenues. UHS anticipates a $75M pre-tax earnings hit in 2026 from these developments, unchanged from prior guidance.

$UHS
Asia

Shenghe Resources' Q1 Profit Jumps 94%, Revenue Climbs 13%

Shenghe Resources' (SHA:600392) net profit attributable to shareholders in the first quarter jumped 94% to 327.3 million yuan from 168.3 million yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share rose year on year to 0.1867 yuan from 0.0960 yuan.The Chinese rare earth miner's operating revenue climbed 13% to 3.38 billion yuan from 2.99 billion yuan in the previous year.

$SHA:600392